KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novavax (NVAX) Other Accumulated Expenses (2016 - 2025)

Novavax has reported Other Accumulated Expenses over the past 13 years, most recently at $137.8 million for Q4 2025.

  • Quarterly results put Other Accumulated Expenses at $137.8 million for Q4 2025, down 37.26% from a year ago — trailing twelve months through Dec 2025 was $137.8 million (down 37.26% YoY), and the annual figure for FY2025 was $137.8 million, down 37.26%.
  • Other Accumulated Expenses for Q4 2025 was $137.8 million at Novavax, roughly flat from $138.3 million in the prior quarter.
  • Over the last five years, Other Accumulated Expenses for NVAX hit a ceiling of $930.1 million in Q4 2022 and a floor of $2.4 million in Q1 2021.
  • Median Other Accumulated Expenses over the past 5 years was $151.3 million (2022), compared with a mean of $303.8 million.
  • Biggest five-year swings in Other Accumulated Expenses: soared 4312.95% in 2022 and later tumbled 74.51% in 2024.
  • Novavax's Other Accumulated Expenses stood at $36.1 million in 2021, then soared by 2479.12% to $930.1 million in 2022, then decreased by 7.38% to $861.4 million in 2023, then crashed by 74.51% to $219.6 million in 2024, then tumbled by 37.26% to $137.8 million in 2025.
  • The last three reported values for Other Accumulated Expenses were $137.8 million (Q4 2025), $138.3 million (Q3 2025), and $132.5 million (Q2 2025) per Business Quant data.